Healthcare services must prepare for a world where Alzheimer’s disease is treatable
12 June 2024
Drugs with the potential to change the course of Alzheimer’s disease are expected to be approved by mid-year in the UK, but the NHS may struggle to ensure equitable access, suggests research led by Professor Rimona Weil, (UCL Queen Square Institute of Neurology).